The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain

F Simonin, K Befort, C Gaveriaux-Ruff, H Matthes, V Nappey, B Lannes, G Micheletti and B Kieffer

Ecole Superieure de Biotechnologie, Illkirch-Graffenstaden, France.

We have used the mouse delta-opioid receptor (mDOR) cDNA to isolate the mDOR gene and its human homologue. In both species the coding region is interrupted by two introns with conserved exon-intron boundaries located after transmembrane domains 1 and 4. Using the polymerase chain reaction and primers based on the sequence of the cloned human delta- opioid receptor (hDOR) gene, we have obtained a full length cDNA encoding the hDOR from SH-SY5Y neuroblastoma cells. The cDNA sequence is 100% identical to the cloned human genomic sequence and 94% identical to the mouse sequence at the protein level. When expressed in COS cells, hDOR displays nanomolar affinities for delta-selective ligands, whereas the affinities for mu- and kappa-selective ligands are in the micromolar range. The delta agonists [D-Ala2, D-Leu5]enkephalin, cyclic [D-penicillamine2,D-penicillamine5]enkephalin, and BW373U86 efficiently decrease forskolin-induced cAMP levels in hDOR-expressing COS cells, indicating functional coupling of the receptor. The distribution of hDOR mRNA in human brain was investigated using delta- selective reverse transcription-polymerase chain reaction amplification, followed by Southern hybridization with a delta-specific probe. The transcript is found in cortical areas, including olfactory bulb, hippocampus, and amygdala, as well as in basal ganglia and hypothalamus. No expression is detected in internal globus pallidus, thalamus, any investigated brainstem structure, or pituitary gland. Taken together, our results indicate similar structural, pharmacological, functional, and anatomical properties for the hDOR and the mDOR and therefore support the use of rodent models for the study of these receptors in opioid function.

Volume 46, Issue 6, pp. 1015-1021, 12/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				U. E. Petaja-Repo, M. Hogue, T. T. Leskela, P. M. H. Markkanen, J. T. Tuusa, and M. Bouvier Distinct Subcellular Localization for Constitutive and Agonist-modulated Palmitoylation of the Human {delta} Opioid Receptor J. Biol. Chem., June 9, 2006; 281(23): 15780 - 15789. [Abstract] [Full Text] [PDF]

				M. J. Kreek, G. Bart, C. Lilly, K. S. Laforge, and D. A. Nielsen Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments Pharmacol. Rev., March 1, 2005; 57(1): 1 - 26. [Abstract] [Full Text] [PDF]

				M. Garnier, P. F. Zaratin, G. Ficalora, M. Valente, L. Fontanella, M.-H. Rhee, K. J. Blumer, and M. A. Scheideler Up-Regulation of Regulator of G Protein Signaling 4 Expression in a Model of Neuropathic Pain and Insensitivity to Morphine J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1299 - 1306. [Abstract] [Full Text] [PDF]

				M. Rubenzik, E. Varga, D. Stropova, W. R. Roeske, and H. I. Yamamura Expression of alpha -Transducin in Chinese Hamster Ovary Cells Stably Transfected with the Human delta -Opioid Receptor Attenuates Chronic Opioid Agonist-Induced Adenylyl Cyclase Superactivation Mol. Pharmacol., November 1, 2001; 60(5): 1076 - 1082. [Abstract] [Full Text]

				A. Miyazato, S. Ueno, K. Ohmine, M. Ueda, K. Yoshida, Y. Yamashita, T. Kaneko, M. Mori, K. Kirito, M. Toshima, et al. Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction Blood, July 15, 2001; 98(2): 422 - 427. [Abstract] [Full Text] [PDF]

				U. E. Petaja-Repo, M. Hogue, A. Laperriere, P. Walker, and M. Bouvier Export from the Endoplasmic Reticulum Represents the Limiting Step in the Maturation and Cell Surface Expression of the Human delta Opioid Receptor J. Biol. Chem., April 28, 2000; 275(18): 13727 - 13736. [Abstract] [Full Text] [PDF]

				A. Hasbi, S. Allouche, F. Sichel, L. Stanasila, D. Massotte, G. Landemore, J. Polastron, and P. Jauzac Internalization and Recycling of delta -Opioid Receptor Are Dependent on a Phosphorylation-Dephosphorylation Mechanism J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 237 - 247. [Abstract] [Full Text]

				C. J. Kotzer, D. W. P. Hay, G. Dondio, G. Giardina, P. Petrillo, and D. C. Underwood The Antitussive Activity of delta -Opioid Receptor Stimulation in Guinea Pigs J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 803 - 809. [Abstract] [Full Text]

				J. A. J. Becker, A. Wallace, A. Garzon, P. Ingallinella, E. Bianchi, R. Cortese, F. Simonin, B. L. Kieffer, and A. Pessi Ligands for kappa -Opioid and ORL1 Receptors Identified from a Conformationally Constrained Peptide Combinatorial Library J. Biol. Chem., September 24, 1999; 274(39): 27513 - 27522. [Abstract] [Full Text] [PDF]

				R. M. Quock, T. H. Burkey, E. Varga, Y. Hosohata, K. Hosohata, S. M. Cowell, C. A. Slate, F. J. Ehlert, W. R. Roeske, and H. I. Yamamura The delta -Opioid Receptor: Molecular Pharmacology, Signal Transduction, and the Determination of Drug Efficacy Pharmacol. Rev., September 1, 1999; 51(3): 503 - 532. [Abstract] [Full Text] [PDF]

				D. Massotte, L. Baroche, F. Simonin, L. Yu, B. Kieffer, and F. Pattus Characterization of delta , kappa , and µ Human Opioid Receptors Overexpressed in Baculovirus-infected Insect Cells J. Biol. Chem., August 8, 1997; 272(32): 19987 - 19992. [Abstract] [Full Text] [PDF]

				J. Zhu, J. Yin, P.-Y. Law, P. A. Claude, K. C. Rice, C. J. Evans, C. Chen, L. Yu, and L.-Y. Liu-Chen Irreversible Binding of cis-(+)-3-Methylfentanyl Isothiocyanate to the [IMAGE] Opioid Receptor and Determination of Its Binding Domain J. Biol. Chem., January 19, 1996; 271(3): 1430 - 1434. [Abstract] [Full Text] [PDF]